Wiley InterScience / Wiley-Liss Inc. / Affymetrix / / /
Facility
National Cancer Institute / Rockville Pike / /
IndustryTerm
treatment for a disease / microarray technology / reaction product / pharmaceutical research / reaction products / written protocol / prognostic classification systems / given organ site / /
MedicalCondition
Cancers / tumor / cancer / tumors / disease / acute lymphocytic leukemia / spontaneous tumors / chronic lymphocytic leukemia / BRCA1 tumor / different tumors / individual disease / breast tumors / large cell lymphoma / same tumors / each tumor / breast tumor / rst tumor / acute myelogenous leukemia / breast cancer / I lung cancer / non-BRCA1-mutated tumors / /
MedicalTreatment
surgery / /
Organization
National Cancer Institute / /
Person
Churchill / Michael D. Radmacher / Dobbin / Kevin Dobbin Biometric / Richard Simon / /
Position
tumors representative / /
ProvinceOrState
Maryland / /
Technology
pharmacogenomic / bioinformatics / often no written protocol / DNA Chip / antibodies / hybridization / gene expression / written protocol / microarray technology / /
Genetic Epidemiology 23:21–[removed]Design of Studies Using DNA Microarrays Richard Simon,* Michael D. Radmacher, and Kevin Dobbin Biometric Research Branch, National Cancer Institute, Bethesda, Maryland DNA microarr